How Mutual Recognition Agreements Speed Up Product Certification

Mutual Recognition Agreements (MRAs) are formal bilateral or multilateral agreements under which two or more countries agree to accept each other's product testing results, certification decisions, or inspection findings as equivalent to their own, eliminating the need for duplicative testing and certification in each market. MRAs operate at two levels: testing laboratory recognition (each country accepts test reports from the other's accredited labs) and certification body recognition (each country accepts the certification decisions of recognized bodies in the partner country). The time and cost reduction from applicable MRAs is substantial -- Taiwan brands that qualify for MRA-based mutual acceptance can reduce certification timelines by 30% to 60% and testing costs by 20% to 50% compared to obtaining full independent certification in each target market.

The economic logic is compelling: a Taiwan electronics brand without MRA access pays SGS Taiwan for IEC testing (USD 3,000), then pays JET Japan for JIS testing (USD 5,000), then pays SGS Australia for AS/NZS testing (USD 2,000) -- three separate test campaigns totaling USD 10,000 and eight to twelve months of elapsed time. With applicable MRAs, the same brand submits one test report to a designated testing organization and requests mutual recognition in partner countries, potentially reducing total testing cost to USD 4,000 and elapsed time to four to six months. MRAs do not eliminate all regulatory requirements -- labeling, registration, and market surveillance obligations in each country remain -- but they remove duplicative testing, which is often the most expensive and time-consuming element of multi-market certification.

Taiwan's Bureau of Standards, Metrology and Inspection (BSMI) has established bilateral MRA-equivalent agreements with several trading partners, though Taiwan's non-member status in international treaty organizations limits formal MRA coverage compared to WTO members. BSMI's most practically useful bilateral arrangement for electronics manufacturers is its participation in the IECEE CB Scheme (IEC System for Conformity Assessment Schemes for Electrotechnical Equipment and Components). The IECEE CB Scheme is not technically an MRA but functions similarly -- it allows manufacturers to obtain a CB Test Report from any IECEE National Certifying Body (NCB), which is then accepted by NCBs in member countries to issue national certification with reduced or zero additional testing. Taiwan's BSMI is a full IECEE NCB member, meaning Taiwan-issued CB Test Certificates are accepted in Japan (JET, JQA), the US (UL, CSA), Australia (SAI Global, TUV Rheinland), and approximately fifty additional markets.

For a Taiwan power supply manufacturer, obtaining a BSMI CB Test Certificate for IEC 62368-1 (audio/video and IT equipment safety) costs USD 3,000 to USD 5,000 and allows UL certification in the US (UL 62368-1) with a top-up fee of approximately USD 1,500 rather than the USD 4,000 to USD 8,000 for independent UL testing. APEC's Mutual Recognition Arrangement for Electrical Equipment (APEC MRA EE) formally recognizes testing laboratories across APEC member economies, and Taiwan participates through BSMI-accredited labs. For EMC (electromagnetic compatibility) testing, BSMI-accredited labs' test results are accepted in Singapore, Australia, and other APEC signatories, though acceptance in the US FCC system remains partial and product-category-dependent.

For Taiwan pharmaceutical and cosmetics manufacturers, the Pharmaceutical Inspection Co-operation Scheme (PIC/S) is the most operationally significant MRA-equivalent framework. PIC/S is an international cooperative arrangement in which member regulatory authorities agree to accept each other's GMP inspection findings -- a facility inspected and found compliant by one PIC/S member's authority does not need to undergo a separate full inspection by another PIC/S member authority for the same manufacturing scope. Taiwan's TFDA (Taiwan Food and Drug Administration) became a PIC/S full member in 2013, covering pharmaceutical manufacturing including active pharmaceutical ingredients and finished dosage forms. For Taiwan pharmaceutical manufacturers supplying products to the US, Australia, and Japan -- all PIC/S members -- TFDA GMP inspection certificates can be leveraged to reduce or streamline foreign regulatory authority inspection requirements.

In Australia, the TGA (Therapeutic Goods Administration) routinely accepts TFDA GMP certificates for Taiwan manufacturers in lieu of conducting full independent GMP inspections, reducing TGA audit lead times from twelve to eighteen months to three to six months. In the US, FDA can accept PIC/S-member GMP findings as part of its foreign inspection risk stratification program -- facilities with current TFDA GMP compliance records may receive lower-frequency FDA inspection scheduling. The practical value for Taiwan pharma exporters is significant: a full FDA pre-approval inspection costs USD 15,000 to USD 50,000 in facility preparation and management time, and PIC/S leveraging can reduce both the frequency and scope of such inspections. For cosmetics, which are not covered by PIC/S, Taiwan TFDA's bilateral cooperation agreements with MHLW Japan cover cosmetics GMP inspection findings, providing a similar facility audit efficiency benefit.

MRAs and recognition schemes have important limitations that Taiwan brands must understand to avoid costly misapplication. First, MRA coverage is product-category-specific -- the IECEE CB Scheme covers specific IEC safety standards but does not cover EMC testing, radio frequency compliance (FCC in the US, ARIB in Japan, ACMA in Australia), or national deviations from IEC standards. A Taiwan electronics brand may use CB Scheme recognition for safety certification but still needs independent national testing for EMC and radio compliance. Second, most MRAs apply only to product safety testing -- they do not cover product registration, labeling approval, or import notification requirements that must be completed independently in each market. Third, recognition is laboratory-to-laboratory, not product-to-product -- even where BSMI-accredited labs' test reports are accepted in partner countries, the manufacturer must still apply for national certification through the target country's NCB or certification authority.

Fourth, MRAs are subject to political and diplomatic factors: Taiwan's non-state status means it participates in MRA-equivalent schemes through functional rather than formal treaty mechanisms, and changes in bilateral relations can affect recognition status. The practical guidance for Taiwan exporters is to use MRAs and CB Scheme recognition to reduce testing duplication -- particularly for IEC safety standards where CB Scheme coverage is comprehensive -- while treating registration, labeling, and national deviation testing as non-MRA items requiring full national compliance effort in each target market. A well-structured multi-market certification plan can save Taiwan brands USD 15,000 to USD 30,000 per product line by optimizing CB Scheme and PIC/S leveraging, while still budgeting correctly for the remaining national-level compliance work.